To investigate the role of TET2 in HCC progression, we determined the expression levels of TET2 in HCC clinical samples by immunohistochemistry (IHC) staining of tissue microarrays (TMAs), which contain 78 pairs of tumor and adjacent normal tissues. Here, TET2 is linked to hepatocellular carcinoma.